{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:24:37Z","timestamp":1793917477707,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>NSAIDs inhibit tumorigenesis in gastrointestinal tissues and have been proposed as coadjuvant agents to chemotherapy. The ability of cancer epithelial cells to adapt to the tumour environment and to resist cytotoxic agents seems to depend on rescue mechanisms such as autophagy. In the present study we aimed to determine whether an NSAID with sensitizing properties such as indomethacin modulates autophagy in gastric cancer epithelial cells. We observed that indomethacin causes lysosomal dysfunction in AGS cells and promotes the accumulation of autophagy substrates without altering mTOR activity. Indomethacin enhanced the inhibitory effects of the lysosomotropic agent chloroquine on lysosome activity and autophagy, but lacked any effect when both functions were maximally reduced with another lysosome inhibitor (bafilomycin B1). Indomethacin, alone and in combination with chloroquine, also hindered the autophagic flux stimulated by the antineoplastic drug oxaliplatin and enhanced its toxic effect, increasing the rate of apoptosis\/necrosis and undermining cell viability. In summary, our results indicate that indomethacin disrupts autophagic flux by disturbing the normal functioning of lysosomes and, by doing so, increases the sensitivity of gastric cancer cells to cytotoxic agents, an effect that could be used to overcome cancer cell resistance to antineoplastic regimes.<\/jats:p>","DOI":"10.1038\/s41598-018-21455-1","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T16:13:30Z","timestamp":1519143210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Indomethacin Disrupts Autophagic Flux by Inducing Lysosomal Dysfunction in Gastric Cancer Cells and Increases Their Sensitivity to Cytotoxic Drugs"],"prefix":"10.1038","volume":"8","author":[{"given":"Jorge","family":"Vallecillo-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"Barrachina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Ortiz-Masi\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Vicente","family":"Esplugues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Calatayud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8536-429X","authenticated-orcid":false,"given":"Carlos","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"21455_CR1","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","volume":"20","author":"E Gurpinar","year":"2014","unstructured":"Gurpinar, E., Grizzle, W. E. & Piazza, G. A. NSAIDs inhibit tumorigenesis, but how? Clin. Cancer. Res. 20, 1104\u20131113 (2014).","journal-title":"Clin. Cancer. Res."},{"key":"21455_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.canlet.2013.09.001","volume":"345","author":"IH Sahin","year":"2014","unstructured":"Sahin, I. H., Hassan, M. M. & Garrett, C. R. Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science. Cancer Lett. 345, 249\u2013257 (2014).","journal-title":"Cancer Lett."},{"key":"21455_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.bjc.6600829","volume":"88","author":"P Ricchi","year":"2003","unstructured":"Ricchi, P., Zarrilli, R., Di Palma, A. & Acquaviva, A. M. Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. Br. J. Cancer 88, 803\u2013807, https:\/\/doi.org\/10.1038\/sj.bjc.6600829 (2003).","journal-title":"Br. J. Cancer"},{"key":"21455_CR4","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3892\/ijo.2014.2686","volume":"45","author":"C Lonnroth","year":"2014","unstructured":"Lonnroth, C., Andersson, M., Asting, A. G., Nordgren, S. & Lundholm, K. Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer. Int. J. Oncol. 45, 2208\u20132220, https:\/\/doi.org\/10.3892\/ijo.2014.2686 (2014).","journal-title":"Int. J. Oncol."},{"key":"21455_CR5","doi-asserted-by":"publisher","first-page":"e107866","DOI":"10.1371\/journal.pone.0107866","volume":"9","author":"SS Soon","year":"2014","unstructured":"Soon, S. S. et al. Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients. PLoS One 9, e107866, https:\/\/doi.org\/10.1371\/journal.pone.0107866 (2014).","journal-title":"PLoS One"},{"key":"21455_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/bjc.2015.336","volume":"113","author":"A Restivo","year":"2015","unstructured":"Restivo, A. et al. Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer. Br. J. Cancer 113, 1133\u20131139, https:\/\/doi.org\/10.1038\/bjc.2015.336 (2015).","journal-title":"Br. J. Cancer"},{"key":"21455_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition. Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"21455_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ijc.29990","volume":"139","author":"Z Huang","year":"2016","unstructured":"Huang, Z., Zhou, L., Chen, Z., Nice, E. C. & Huang, C. Stress management by autophagy: Implications for chemoresistance. Int. J. Cancer 139, 23\u201332 (2016).","journal-title":"Int. J. Cancer"},{"key":"21455_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00535-015-1137-1","volume":"51","author":"C Hernandez","year":"2016","unstructured":"Hernandez, C. et al. Aspirin-induced gastrointestinal damage is associated with an inhibition of epithelial cell autophagy. J. Gastroenterol. 51, 691\u2013701 (2016).","journal-title":"J. Gastroenterol."},{"key":"21455_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00109-016-1491-3","volume":"95","author":"CY Ock","year":"2017","unstructured":"Ock, C. Y. et al. Genetic ablation or pharmacologic inhibition of autophagy mitigated NSAID-associated gastric damages. J. Mol. Med. 95, 405\u2013416, https:\/\/doi.org\/10.1007\/s00109-016-1491-3 (2017).","journal-title":"J. Mol. Med."},{"key":"21455_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1124\/jpet.115.226431","volume":"355","author":"S Harada","year":"2015","unstructured":"Harada, S. et al. Autophagy Deficiency Diminishes Indomethacin-Induced Intestinal Epithelial Cell Damage through Activation of the ERK\/Nrf2\/HO-1 Pathway. J. Pharmacol. Exp. Ther. 355, 353\u2013361, https:\/\/doi.org\/10.1124\/jpet.115.226431 (2015).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"21455_CR12","first-page":"1072","volume":"48","author":"PK Lala","year":"1988","unstructured":"Lala, P. K. & Parhar, R. S. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ. Cancer Res. 48, 1072\u20131079 (1988).","journal-title":"Cancer Res."},{"key":"21455_CR13","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4161\/cc.7.7.5620","volume":"7","author":"F Jamshidi","year":"2008","unstructured":"Jamshidi, F., Zhang, J., Harrison, J. S., Wang, X. & Studzinski, G. P. Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1,25-dihydroxyvitamin D3 involves Raf1 but not Erk 1\/2 signaling. Cell Cycle 7, 917\u2013924 (2008).","journal-title":"Cell Cycle"},{"key":"21455_CR14","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1124\/mol.108.053546","volume":"75","author":"L Yu","year":"2009","unstructured":"Yu, L. et al. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity. Mol. Pharmacol. 75, 1364\u20131373 (2009).","journal-title":"Mol. Pharmacol."},{"key":"21455_CR15","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/jid.2013.471","volume":"134","author":"AK-W Tse","year":"2014","unstructured":"Tse, A. K.-W. et al. Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin. J. Invest. Dermatol. 134, 1397\u20131407 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"21455_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.molmed.2014.01.009","volume":"20","author":"MT Gyparaki","year":"2014","unstructured":"Gyparaki, M. T. & Papavassiliou, A. G. Lysosome: the cell\u2019s \u2018suicidal bag\u2019 as a promising cancer target. Trends Mol. Med. 20, 239\u2013241, https:\/\/doi.org\/10.1016\/j.molmed.2014.01.009 (2014).","journal-title":"Trends Mol. Med."},{"key":"21455_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-pharmtox-010715-103101","volume":"57","author":"SM Davidson","year":"2017","unstructured":"Davidson, S. M. & Vander Heiden, M. G. Critical Functions of the Lysosome in Cancer Biology. Annu. Rev. Pharmacol. Toxicol. 57, 481\u2013507, https:\/\/doi.org\/10.1146\/annurev-pharmtox-010715-103101 (2017).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"21455_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1083\/jcb.201602082","volume":"212","author":"S Gowrishankar","year":"2016","unstructured":"Gowrishankar, S. & Ferguson, S. M. Lysosomes relax in the cellular suburbs. J. Cell Biol. 212, 617\u2013619 (2016).","journal-title":"J. Cell Biol."},{"key":"21455_CR19","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1242\/jcs.196287","volume":"129","author":"J Pu","year":"2016","unstructured":"Pu, J., Guardia, C. M., Keren-Kaplan, T. & Bonifacino, J. S. Mechanisms and functions of lysosome positioning. J. Cell Sci. 129, 4329\u20134339 (2016).","journal-title":"J. Cell Sci."},{"key":"21455_CR20","doi-asserted-by":"publisher","first-page":"35769","DOI":"10.1074\/jbc.M113.511212","volume":"288","author":"M Li","year":"2013","unstructured":"Li, M. et al. Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity. J. Biol. Chem. 288, 35769\u201335780 (2013).","journal-title":"J. Biol. Chem."},{"key":"21455_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4161\/15548627.2014.984277","volume":"11","author":"O Florey","year":"2015","unstructured":"Florey, O., Gammoh, N., Kim, S. E., Jiang, X. & Overholtzer, M. V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation. Autophagy 11, 88\u201399 (2015).","journal-title":"Autophagy"},{"key":"21455_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/onc.2015.99","volume":"35","author":"VW Rebecca","year":"2016","unstructured":"Rebecca, V. W. & Amaravadi, R. K. Emerging strategies to effectively target autophagy in cancer. Oncogene 35, 1\u201311 (2016).","journal-title":"Oncogene"},{"key":"21455_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI78652","volume":"125","author":"G Kroemer","year":"2015","unstructured":"Kroemer, G. Autophagy: a druggable process that is deregulated in aging and human disease. J. Clin. Invest. 125, 1\u20134 (2015).","journal-title":"J. Clin. Invest."},{"key":"21455_CR24","doi-asserted-by":"publisher","first-page":"7654","DOI":"10.1158\/0008-5472.CAN-06-4415","volume":"67","author":"S Brouxhon","year":"2007","unstructured":"Brouxhon, S. et al. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism. Cancer Res. 67, 7654\u20137664, https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4415 (2007).","journal-title":"Cancer Res."},{"key":"21455_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0006-2952(03)00396-4","volume":"66","author":"E Deharo","year":"2003","unstructured":"Deharo, E., Barkan, D., Krugliak, M., Golenser, J. & Ginsburg, H. Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels. Biochem. Pharmacol. 66, 809\u2013817 (2003).","journal-title":"Biochem. Pharmacol."},{"key":"21455_CR26","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.3892\/ol.2016.4493","volume":"11","author":"W Sun","year":"2016","unstructured":"Sun, W. & Chen, G. Impact and mechanism of non-steroidal anti-inflammatory drugs combined with chemotherapeutic drugs on human lung cancer-nude mouse transplanted tumors. Oncol. Lett. 11, 4193\u20134199 (2016).","journal-title":"Oncol. Lett."},{"key":"21455_CR27","doi-asserted-by":"publisher","first-page":"16520","DOI":"10.1073\/pnas.1415178111","volume":"111","author":"B Leibowitz","year":"2014","unstructured":"Leibowitz, B. et al. BID mediates selective killing of APC-deficient cells in intestinal tumor suppression by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. USA 111, 16520\u201316525 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"21455_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3164\/jcbn.16-69","volume":"60","author":"HJ Lee","year":"2017","unstructured":"Lee, H. J., Park, J. M. & Hahm, K. B. Mitigated NSAID-induced apoptotic and autophagic cell death with Smad7 overexpression. J. Clin. Biochem. Nutr. 60, 55\u201362, https:\/\/doi.org\/10.3164\/jcbn.16-69 (2017).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"21455_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbrc.2009.02.140","volume":"382","author":"WK Wu","year":"2009","unstructured":"Wu, W. K. et al. Inhibition of cyclooxygenase-1 lowers proliferation and induces macroautophagy in colon cancer cells. Biochem. Biophys. Res. Commun. 382, 79\u201384, https:\/\/doi.org\/10.1016\/j.bbrc.2009.02.140 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"21455_CR30","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.bcp.2011.03.019","volume":"81","author":"SK Chiou","year":"2011","unstructured":"Chiou, S. K., Hoa, N. & Hodges, A. Sulindac sulfide induces autophagic death in gastric epithelial cells via survivin down-regulation: a mechanism of NSAIDs-induced gastric injury. Biochem. Pharmacol. 81, 1317\u20131323, https:\/\/doi.org\/10.1016\/j.bcp.2011.03.019 (2011).","journal-title":"Biochem. Pharmacol."},{"key":"21455_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4161\/auto.6.2.11124","volume":"6","author":"S Huang","year":"2010","unstructured":"Huang, S. & Sinicrope, F. A. Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells. Autophagy 6, 256\u2013269 (2010).","journal-title":"Autophagy"},{"key":"21455_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tcb.2014.09.001","volume":"25","author":"CM Kenific","year":"2015","unstructured":"Kenific, C. M. & Debnath, J. Cellular and metabolic functions for autophagy in cancer cells. Trends Cell Biol. 25, 37\u201345 (2015).","journal-title":"Trends Cell Biol."},{"key":"21455_CR33","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.1158\/0008-5472.CAN-16-0722","volume":"76","author":"DA Gewirtz","year":"2016","unstructured":"Gewirtz, D. A. The Challenge of Developing Autophagy Inhibition as a Therapeutic Strategy. Cancer Res. 76, 5610\u20135614, https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0722 (2016).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21455-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:46:10Z","timestamp":1671590770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21455-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21455"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21455-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"7 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3593"}}